Standard Chemotherapy Plus Novel Drugs for Advanced Pancreatic Cancer
This trial tests the effectiveness of three different novel drugs, including immunotherapy, added to standard treatment for advanced pancreatic cancer.
Genetic Testing Leads Me to a PARP Inhibitor Trial
Harvey Parker had genetic testing as part of his initial pancreatic cancer treatment. The BRCA2 mutation led him to a PARP inhibitor clinical trial when the cancer returned.
New Guidelines on the Use of Radiation for Pancreatic Cancer Treatment
New clinical guidelines from the American Society for Radiation Oncology will help clarify the best uses of radiation treatment for pancreatic cancer.
Looking Back at the Year in Research: 2019
The research highlights of 2019 include: approval of a PARP inhibitor, artificial intelligence to diagnose pancreatic cysts, and updated radiation guidelines.
Testing Treatment Combinations to Make Surgery More Effective
Researchers are looking at losartan and nivolumab combined with standard protocol of chemotherapy and radiation to see either drug or a combination is more effective.
For Pancreatic Cancer Patients, Pain Control Through Targeted Radiotherapy
Dr. Yaacov Lawrence is using celiac plexus radiotherapy in a clinical trials to target a source of pain for pancreatic cancer patients.
Radiation Therapy To Fight Pancreatic Cancer
Dr. Smith Apisarnthanarax, a radiation oncologist, details the different types of radiation therapy given to pancreatic cancer patients.
Molecular Profiling Leads to Non-Standard Pancreatic Cancer Treatments
With stage IV pancreatic cancer, Rick Baker realized he needed to try many different treatments, including clinical trials.
Aiming to Improve Immunotherapy for Pancreatic Cancer
Dr. Deirdre Cohen discusses clinical trials that aim to improve the effectiveness of immunotherapy for pancreatic cancer.
A Charley Horse Led to Pancreatic Neuroendocrine Tumor Discovery
Mark Head thought he had a Charley horse, but it turned out to be a more serious deep vein thrombosis. A scan for the source found a pancreatic neuroendocrine tumor.